Literature DB >> 29516289

Are Doctors the Best People to Manage Gout? Is There a Role for Nurses and Pharmacists?

Zahira Latif1, Abhishek Abhishek2.   

Abstract

PURPOSE OF REVIEW: To discuss alternate models of long-term gout management RECENT
FINDINGS: Nurse-led care of gout appears to improve the uptake of and adherence to urate-lowering treatment in a research setting. Less impressive improvements were achieved with pharmacist-led remote management of gout; however, both strategies were more effective than usual primary care provider management of gout. Individualised education about gout, patient involvement in decision-making, and access to trained support in managing side-effects and gout flares can improve the uptake of fine and adherence to urate-lowering treatment. This may be best achieved with nurse-led care of gout. However, further research is required to evaluate if the model of nurse-led care of gout can be implemented in routine clinical practice and in different healthcare systems.

Entities:  

Keywords:  Gout; Nurse-led care; Pharmacist-led care; Urate-lowering treatment

Mesh:

Substances:

Year:  2018        PMID: 29516289     DOI: 10.1007/s11926-018-0722-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  42 in total

1.  British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.

Authors:  Kelsey M Jordan; J Stewart Cameron; Michael Snaith; Weiya Zhang; Michael Doherty; Jonathan Seckl; Aroon Hingorani; Richard Jaques; George Nuki
Journal:  Rheumatology (Oxford)       Date:  2007-05-23       Impact factor: 7.580

2.  A Pharmacist-Staffed, Virtual Gout Management Clinic for Achieving Target Serum Uric Acid Levels: A Randomized Clinical Trial.

Authors:  Robert Goldfien; Alice Pressman; Alice Jacobson; Michele Ng; Andrew Avins
Journal:  Perm J       Date:  2016-07-01

Review 3.  Medication adherence in gout: a systematic review.

Authors:  Mary A De Vera; Greg Marcotte; Sharan Rai; Jessica S Galo; Vidula Bhole
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-10       Impact factor: 4.794

4.  Comparison of drug adherence rates among patients with seven different medical conditions.

Authors:  Becky A Briesacher; Susan E Andrade; Hassan Fouayzi; K Arnold Chan
Journal:  Pharmacotherapy       Date:  2008-04       Impact factor: 4.705

5.  Barriers to Care in Gout: From Prescriber to Patient.

Authors:  Stefanie Vaccher; Diluk R W Kannangara; Melissa T Baysari; Jennifer Reath; Nicholas Zwar; Kenneth M Williams; Richard O Day
Journal:  J Rheumatol       Date:  2015-11-15       Impact factor: 4.666

6.  Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Christian Mallen; Weiya Zhang; Michael Doherty
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

Review 7.  Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.

Authors:  Tahir Kanji; Mandark Gandhi; Catherine M Clase; Robert Yang
Journal:  BMC Nephrol       Date:  2015-04-19       Impact factor: 2.388

8.  Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study.

Authors:  Robert D Goldfien; Michele S Ng; Goldie Yip; Alice Hwe; Alice Jacobson; Alice Pressman; Andrew L Avins
Journal:  BMJ Open       Date:  2014-01-10       Impact factor: 2.692

9.  Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study.

Authors:  Jiunn-Horng Chen; Joung-Liang Lan; Chi-Fung Cheng; Wen-Miin Liang; Hsiao-Yi Lin; Gregory J Tsay; Wen-Ting Yeh; Wen-Harn Pan
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

10.  Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.

Authors:  Jasvinder A Singh; Rekha Ramachandaran; Shaohua Yu; Jeffrey R Curtis
Journal:  BMC Cardiovasc Disord       Date:  2017-03-14       Impact factor: 2.298

View more
  1 in total

1.  Evaluation of urate-lowering therapy in hyperuricemia patients: a systematic review and Bayesian network meta-analysis of randomized controlled trials.

Authors:  Yu-Jiun Lin; Shiyng-Yu Lin; Chang-Hsien Lin; Sen-Te Wang; Shy-Shin Chang
Journal:  Clin Rheumatol       Date:  2020-01-21       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.